Table 1.

Distribution of amplification rates of MYC and UBR5 in The Cancer Genome Atlas patient samples in the indicated cancer types.

BreastPancreasOvaryLymphoid
Total number of samples1,08018357948
No. of samples with either MYC and/or UBR5 amplifications (% of total)247 (22.8%)23 (12.5%)254 (43.8%)1 (2%)
Cancers with MYC amplifications only (% of amplifications)28%61%54%1%
Cancer with UBR5 amplifications only (% of amplifications)7%0%4%0%
Cancers with MYC/UBR5 coamplifications (% of amplifications)65%39%42%0%